Abstract
Rational strategies for the development of novel antidepressant agents are based on an analysis of perceived therapeutic needs, which in turn derive from the inadequacies of the therapies that are currently available. The traditional (first-generation) antidepressants suffer from three major drawbacks: They have unacceptable side effects; their efficacy is low; and their therapeutic effects develop slowly, typically requiring 3–4 wk of treatment before clear improvements in mood are apparent. Since the 1970s, these three problems have formed the major therapeutic targets in antidepressant drug development, since any newly developed agent could only be marketed on the basis of an improvement over traditional agents in one or more of these areas.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Sitsen, J. M. A. and Montgomery, S. A. (1994) The pharmacological treatment of depression and its problems, in: Handbook of Depression and Anxiety ( Den Boer, J. A. and Sitsen, J. M. A., eds.). Marcel Dekker, New York, pp. 349–377.
Prange, A. (1987) L-triiodothyronine (T3): its place in the treatment of TCA-resistant depressed patients, in: Treating Resistant Depression ( Zohar, J. and Belmaker, R. H., eds.). PMA, New York, pp. 147–162.
De Montigny, C. and Cournoyer, G. (1987) Lithium addition in treatment-resistant major depression, in: Treating Resistant Depression ( Zohar, J. and Belmaker, R. H., eds.). PMA, New York, pp. 147–162.
Wachtel, H. (1983) Potential antidepressant activity of rolipram and other selective cyclic adenosine 3’,5’-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22, 267–272.
Layer, R. T., Popik, P., Nowak, G., Paul, I. A., Trullas, R., and Skolnick, P. (1996) A unified theory of antidepressant action: evidence for adaptation of the N-methyl-D-aspartate (NMDA) receptor following chronic antidepressant treatments, in: Ion Channel Pharmacology (Cena, V. and Soria, B., eds.). Oxford University Press, London, in press.
Smadja, C., Maldonado, R., Turcaud, S., Fournie-Zaluski, M. C., and Roques, B. P. (1995) Opposite effects of CCK-A and CCK-B 95 receptors in the modulation of endogenous enkephalin antidepressant-like effects. Psychopharmacology 120, 400–408.
Tejedor-Real, P., Mico, J. A., Maldonado, R., Roques, B. P., and Gibert-Rahola, J. (1993) Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading. enzymes on a model of depression in the rat. Biol. Psychiatry 34, 100–107.
Andrews, J. M. and Nemeroff, C. B. (1994) Contemporary management of depression. Am. J. Med. 97, 24S - 32S.
Rampello, L., Nicoletti, G., and Raffaele, R. (1991) Dopaminergic hypothesis of retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatrica Scand. 84, 552–554.
Derivan, A., Entsuah, A. R., and Kikta, D. (1995) Venlafaxine: measuring the onset of antidepressant action. Psychopharmacol. Bull. 31, 439–447.
De Montigny, C., Chaput, Y., and Blier, R. (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J. Clin. Psychiatry 51 (Suppl), 4–8.
Artigas, F., Perez, V., and Alvarez, E. (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51, 248–251.
Willner, R (1984) The validity of animal models of depression. Psychopharmacology 83, 1–16.
Willner, R. (1990) Animal models of depression: an overview. Pharmacol. Ther. 45, 425–455.
Borsini. F. and Meli, A. (1990) The forced swimming test: its contribution to the understanding of the mechanisms of action of antidepressants, in: Dopamine and Mental Depression ( Gessa, G. L. and Serra, G., eds.). Pergamon, Oxford, pp. 63–76.
Sarges, R., Howard, H. R., Browne, R. G., Lebel, L. A., Seymour, P.A., and Koe, B. K. (1990) 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. J. Med. Chem. 33, 2240–2254.
Flugy, A., Gagliano, M., Cannizzaro, C., Novara, V., and Cannizzaro, G. (1992) Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats. Eur. J. Pharmacol. 214, 233–238.
Drugan, R., Ryan, S. M., Minor, T. R., and Maier, S. F. (1984) Librium prevents the analgesia and shuttle-box escape deficits typically observed following inescapable shock. Pharmacol. Biochem. Behay. 21, 749–754.
De Pablo, J. M., Ortiz-Caro, J., Sanchez-Santed, F., and Guillamon, A. (1991) Effects of diazepam, pentobarbital, scopolamine and the timing of saline injection on learned immobility in rats. Physiol. Behay. 50, 895–899.
Willner, P., Towell, A., Sampson, D., Sophokleous, S., and Muscat, R. (1987) Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 93, 358–364.
Willner, R, Muscat, R., and Papp, M. (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehay. Rev. 16, 525–534.
Monleon, S., D’Aquila, R, Parra, A., Simon, V. M., Brain, R. F., and Willner, P. (1994) Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117, 453–457.
Muscat, R. and Willner, P. (1992) Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci. Biobehay. Rev. 16, 507–517.
American Psychiatric Association (1994) DSM IV-Diagnostic and Statistical Manual of Psychiatric Disorders, 4th ed. American Psychiatric Association, Washington DC.
Ayensu, W.K., Pucilowski, O., Mason, G. A., Overstreet, D. H., Revzani, A. H., and Janowsky, D. S. (1995) Effects of chronic mild stress on serum complement activity, saccharin preference and corticosterone levels in Flinders lines of rats. Physiol. Behay. 57, 165–169.
Willner, R, Klimek, V., Golembiowska, K., and Muscat, R. (1991) Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 19, 79–84.
Muscat, R., Kyprianou, T., Osman, M., Phillips, G., and Willner, P. (1991) Sweetness-dependent facilitation of sucrose drinking by raclopride is unrelated to calorie content. Pharmacol. Biochem. Behay. 40, 209–213.
Papp, M., Willner, P., and Muscat, R. (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104, 255–259.
Muscat, R., Papp, M., and Willner, P. (1992) Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline Psychopharmacology 109, 433–438.
Matthews, K., Forbes, N., and Reid, I. C. (1995) Sucrose consumption as a hedonic measure following chronic unpredictable mild streess. Physiol. Behay. 57, 241–248.
Willner, P., Moreau, J.-M., Nielsen, C., Papp, M., and Sluzewska, A. (1996) Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol. Behay. 60, 129–134.
Papp, M., Lappas, S., Muscat, R., and Willner, P. (1992) Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. J. Psychopharmacol. 6, 352–356.
Moreau, J.-L., Jenck, F., Martin, J. R., Mortas, P., and Haefely, W. E. (1992) Antidepressant treatment prevents chronic mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behaviour in rats. Eur. Neuropsychopharmacol. 2, 43–49.
Moreau, J.-L., Jenck, F., Martin, J. R., Mortas, P., and Haefely, W. E. (1993) Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry, 26, 30–33.
D’Aquila, P., Brain, P. F., and Willner, P. (1994) Effects of chronic mild stress in behavioural tests relevant to anxiety and depression. Physiol. Behay. 56, 861–867.
Gorka, Z., Moryl, E., and Papp, M. (1996) The effect of chronic mild stress on circadian rhythms in the locomotor activity of rats. Pharmacol. Biochem. Behay. 54, 229–234.
a. Cheeta, S., Ruigt, G., van Proosdij, J., and Willner, P. (1997) Changes in sleep architecture following chronic mild stress. Biol. Psychiatry,in press.
Moreau, J.-L., Scherschlict, R., Jenck, F., and Martin, J. R. (1997) Chronic mild stress-induced anhedonia model of depression: sleep abnormalities and curative effects of electroshock treatment. Behay. Pharmacol. 6, 682–687.
Kubera, M., Basta-Kaim, A., Papp, M., and Skowron-Cendrzak, A. (1994) Immunological changes after chronic mild stress and psychotropic drugs administration. 12th European Immunology Meeting (abstracts), p. 37.
Kubera, M., Basta-Kaim, A., and Papp, M. (1995) The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to chronic mild stress model of depression. Immunopharmacology 30, 225–230.
Sluzewska, A., Gryska, K., and Mackiewicz, A. (1996) Acute phase proteins in chronic mild stress model of depression. Behay. Pharmacol. 7 (Suppl 1), 105–106.
Willner, P. (1991) Animal models as simulations of depression. TIPS 12, 131–136.
Papp, M., Moryl, E., and Willner, P. (1996) Pharmacological validation of the chronic mild stress model of depression. Eur. J. Pharmacol. 296, 129–136.
Muscat, R., Sampson, D., and Willner, P. (1990) Dopaminergic mechanisms of imipramine action in an animal model of depression. Biol. Psychiatry 28, 223–230.
Sampson, D., Muscat, R., and Willner, P. (1991) Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology 104, 491–495.
Przegalinski, E., Moryl, E., and Papp, M. (1995) The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression. Neuropharmacology 34, 1305–1310.
Sluzewska, A. and Szczawinska, K. (1996) The effects of pindolol addition to fluvoxamine and buspirone in chronic mild stress model of depression. Behay. Pharmacol. 7 (Suppl 1), 105.
Cheeta, S., Broekkamp, C., and Willner, P. (1994) Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer. Psychopharmacology 116, 523–528.
Moreau, J.-L., Jenck, F., Martin, J. R., and Mortas, P. (1994) Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression. J. Psychiatr. Neurosci. 19, 51–56.
Sluzewska, A. and Szczawinska, K. (1996) Lithium potentiation of antidepressants in chronic mild stress model of depression in rats. Behay. Pharmacol. 7 (Suppl 1), 105.
Sluzewska, A. and Nowakowska, E. (1994) The effects of carbamazepine, lithium and ketoconazole in chronic mild stress model of depression in rats. Behay. Pharmacol. 5 (Suppl 1), 86.
Thakore, J. H. and Dinan, T. G. (1995) Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol. Psychiatry 37, 364–368.
Smadja, C., Ruiz, F., Turcaud, S., Roques, B. P., and Maldonado, R. (1995) Effects induced by endogenous and exogenous opioids in different animal models of depression: modulation by the CCK system. Analgesia 1, 742–745.
Willner, P. (1985) Depression: A Psychobiological Synthesis. Wiley, New York.
Cutler, N. R., Keppel Hesselink, J. M., and Sramek, J. J. (1994) A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18, 447–463.
Amsterdam, J. D. (1992) Gepirone, a selective serotonin (5HT(1A)) partial agonist in the treatment of major depression. Prog. Neuropsychopharmacol. Biol. Psychiatr. 16, 271–280.
Willner, P. and Scheel-Kruger, J., eds. (1991) The Mesolimbic Dopamine System: From Motivation to Action. Wiley, New York.
Maj, J. (1990) Behavioral effects of antidepressant drugs given repeatedly on the dopaminergic system, in: Dopamine and Mental Depression ( Gessa, G. L. and Serra, G., eds.). Pergamon, Oxford, 139–146.
Papp, M., Klimek, V., and Willner, R. (1994) Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115, 441–446.
Papp, M., Muscat, R., and Willner, R (1993) Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology 110, 152–158.
Stamford, J. A., Muscat, R., O’Connor, J. J., Patel, J., Trout, S. J., Wieczorek, W. J., Zruk, Z. L., and Willner, P. (1991) Subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine. Psychopharmacology 105, 275–282.
Zebrowska-Lupina, I., Ossowska, G., and Klenk-Majewska, B. (1992) The influence of antidepressants on aggressive behavior in stressed rats: the role of dopamine. Pol. J. Pharmacol. Pharm. 44, 325–335.
Muscat, R., Papp, M., and Willner, R. (1992) Antidepressant-like actions of dopamine agonists in an animal model of depression. Biol. Psychiatry 31, 937–946.
Papp, M., Muscat, R., and Willner, R. (1993) Behavioural sensitization to a dopamine agonist is associated with recovery from stress-induced anhedonia. Psychopharmacology 110, 159–164.
Willner, P., Lappas, S., Cheeta, S., and Muscat, R. (1994) Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology 115, 454–462.
Willner, P. (1994) Dopaminergic mechanisms in depression and mania, in: Psychopharmacology: The Fourth Generation of Progress ( Bloom, F. E. and Kupfer, D. J., eds.). Raven, New York, pp. 921–931.
Moreau, J.-L., Borgulya, J., Jenck, E, and Martin, J. R. (1994) Tolcapone: a potential new antidepressant detected in a novel animal model of depression. Behay. Pharmacol. 5, 344–351.
Mierau, J., and Schingnitz, G. (1992) Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Eur. J. Pharmacol. 215, 161–170.
Cador, M., Robbins, T. W., Everitt, B. E., Simon, H., Le Moal, M., and Stinus, L. (1991) Limbic-striatal interactions in reward processes: modulation by the dopaminergic system, in: The Mesolimbic Dopamine System: From Motivation to Action. ( Willner, P. and Scheel-Kruger, J., eds.), Wiley, New York, pp. 225–250.
Papp, M., Klimek, V., and Willner, P. (1994) Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology 114, 309–314.
Bijak, M. and Papp, M. (1995) The effect of chronic treatment with imipramine on the responsiveness of hippocampal CA1 neurons to phenylephrine and serotonin in a chronic mild stress model of depression. Eur. Neuropsychopharmacol. 5, 43–48.
Cesana, R., Ciprandi, C., and Borsini, F. (1995) The effect of BIMT 17, a new potential antidepressant, in the forced swimming test in mice. Behay. Pharmacol. 7, 688–694.
Borsini, F. (1996) Antidepressants: behavioral consequences of 5-HT postsynaptic agonism. Behay. Pharmacol. 7 (Suppl. 1), 10.
Willner, P. (1995) Animal models of depression: Validity and applications. In: Depression and Mania: From Neurobiology to Treatment ( Gessa, G. L., Fratta, W., Pani, L., and Serra, G., eds.). Raven, New York, pp. 19–41.
McCance-Katz, E., Price, L. H., Charney, D. S., and Heninger, G. R. (1992) Serotonergic function during lithium augmentation of refractory depression. Psychopharmacology 108, 93–97.
Papp, M., Nalepa, I., and Vetulani, J. (1994) Reversal by impramine of beta-adrenoceptor up-regulation induced in a chronic mild stress model of depression. Eur. J. Pharmacol. 261, 141–147.
Cheeta, S. (1995) A model of depression: assessment of the validity of the chronic mild stress procedure. PhD thesis, University of Wales.
Nowak, G., Papp, M., and Paul, I. A. (1995) Adaptation of NMDA receptors in animal models of depression: chronic mild stress (CMS). Soc. Neurosci. Abstracts 21, 2107.
Papp, M. and Moryl, E. (1994) Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur J. Pharmacol. 263, 1–7.
Papp, M. and Moryl, E. (1997) Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression. Eur. J. Pharmacol.,in press.
Dziedzicka-Wasylewska, M. and Papp, M. (1996) Effect of chronic mild stress and prolonged treatment with imipramine on the levels of endogenous met-enkephalin in the rat dopaminergic mesolimbic system. Pol. J. Pharmacol. 48, 53–56.
Dauge, V., Bertrand, E., Smadja, C., Fournie-Zaluska, M. C., and Roques, B. P. (1996) Analysis of extracellular levels of met-enkephaline in the nucleus accumbens of rats submitted to a chronic unpredictable mild stress regimen. Behay. Pharmacol. 7 (Suppl. 1), 24.
Fibiger, H. C. (1991) The dopamine hypotheses of schizophrenia and depression: contradictions and speculations, in: The Mesolimbic Dopamine System: From Motivation to Action ( Willner, P. and Scheel-Kruger, J., eds.). John Wiley, Chichester, pp. 615–637.
Willner, P., Sampson, D., Phillips, G., Fichera, R., Foxlow, P., and Muscat, R. (1989) Effects of isolated housing and chronic antidepressant treatment on cooperative social behaviour in rats. Behay. Pharmacol. 1, 85–90.
Broekkamp, C. L., Garrigou, D., and Lloyd, K. G. (1980) Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats. Pharmacol. Biochem. Behay. 13, 643–646.
Redmond, A. M., Kelly, J. P., and Leonard, B. E. (1994) Effect of paroxetine and fluvoxamine on behavioural changes in a number of paradigms in the olfactory bulbectomized rat model of depression. J. Serotonin Res. 3, 199–205.
Gardner, R. (1982) Mechanisms in manic-depressive disorder: an evolutionary model. Arch. Gen. Psychiatry 39, 1436–1441.
Mitchell, P. J. and Redfern, P. H. (1992) Chronic treatment with chlomipramine and mianserin increases the hierarchical position of subdominants rats housed in triads. Behay. Pharmacol. 3, 239–247.
Willner, P., D’Aquila, P., Coventry, T., and Brain, P. (1995) Loss of social status: preliminary evaluation of a novel animal model of depression. J. Psychopharmacol. 9, 207–213.
Koolhaas, J. M., Hermann, P. M., Kemperman, C., Bohus, B., van den Hoofdakker, R. H., and Beersma, D. G. M. (1990) Single social defeat in male rats induces a gradual but long lasting behavioral change: a model of depression? Neurosci. Res. Comm. 7, 35–41.
Kudryatseva, N. N., Bakshtanowskaya, I. V., and Koryakina, L. A. (1991) Social model of depression in mice of C57BL/6J strain. Pharmacol. Biochem. Behay. 38, 315–320.
Blanchard, D. C., Spencer, R. L., Weiss, S. M., Blanchard, R. J., McEwen, B., and Sakai, R. R. (1995) Visible burrow system as a model of chronic social stress: behavioral and neuroendocrine correlates. Psychoneuroendocrinology 20, 117–134.
Coventry, T., D’Aquila, R, Brain, P., and Willner, R. (1997) Social influences on morphine conditioned place preference. Behay. Pharmacol.,in press.
Vogel, G. W., Neill, D., Hagler, M., and Kors, D. (1990) A new animal model of depression: a summary of present findings. Neurosci. Biobehay. Rev. 14, 49–63.
Hilakivi, L. A., Taira, R., Hilakivi, I., and Loikas, P. (1988) Neonatal treatment with monoamine uptake inhibitors alters late response in behavioral `despair’ test to beta and GABA-B receptor agonists. Pharmacol. Toxicol. 63, 57–61.
Ogawa, T., Mikuni, M., Kuroda, Y, Muneoka, K., Mori, K. J., and Takahashi, K. (1994) Effects of the altered serotonergic signalling by neonatal treatment with 5,7-dihydroxytryptamine, ritanserin or clomipramine on the adrenocortical stress response and the glucocorticoid receptor binding in the hippocampus in adult rats. J. Neural Transm. 96, 113–123.
Dwyer, K. D. and Roy, E. J. (1993) Juvenile desipramine reduces adult sensitivity to imipramine in two behavioral tests. Pharmacol. Biochem. Behay. 45, 201–207.
Ladd, C. O., Owens, M. J., and Nemeroff, C. B. (1996) Persistent changes in corticotropinreleasing factor neuronal systems induced by maternal deprivation. Endocrinology 137, 1212–1218.
Matthews, K., Wilkinson, L. S., and Robbins, T. W. (1996) Repeated maternal separation of preweanling rats attenuates behavioral responses to primary and conditioned incentives in adulthood. Physiol. Behay. 59, 99–107.
Overstreet, D. H. (1993) The Flinders sensitive line rats: a genetic animal model of depression. Neurosci. Biobehay. Rev. 17, 51–68.
Pucilowski, O., Overstreet, D, H., Rezvani, A. H., and Janowsky, D. S. (1993) Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol. Behay. 54, 1215–1220.
Overstreet, D. H., Pucilowski, O., and Rezvani, A. (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology 121, 27–37.
Cools, A. R., Brachten, R., Heeren, D., Willemen, A., and Ellenbroek, B. (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res. Bull. 24, 49–69.
Overstreet, D. H., Rezvani, A., and Janowsky, D. S. (1992) Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol. Psychiatry 31, 919–936.
Plomin, R. and McClearn, G. E. (1993) Quantitative trait loci (QTL) analyses and alcohol-related behaviors. Behay. Genet. 23, 197–211.
Gold, L. H. (1996) Integration of molecular biological techniques and behavioural pharmacology. Behay. Pharmacol. 7, 589–615.
Hilakivi-Clarke, L. A., Arora, P. K., Sabol, M. B., Clarke, R., Dickson, R. B. and Lippman, M. E. (1992) Alterations in behavior, steroid hormones and natural killer cell activity in male transgenic TGF alpha mice. Brain Res. 588, 97–103.
Beaulieu, S., Rousse, I., Gratton, A., Barden, N., and Rochford, J. (1994) Behavioral and endocrine impact of impaired type II glucocorticoid receptor function in a transgenic mouse model. Ann. NY Acad. Sci. 746, 388–391.
Hilakivi-Clarke, L. A. and Goldberg, R. (1993) Effects of tryptophan and serotonin uptake inhibitors on behaviour in male transgenic transforming growth factor alpha mice. Eur. J. Pharmacol. 237, 101–108.
Montkowski, A., Barden, N., Wotjak, C., Stec, I., Ganster, J., Meaney, M., Engelmann, M., Reul, J. M. H. M., Landgraf, R., and Holsboer, F. (1995) Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7, 841–845.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Willner, P., Papp, M. (1997). Animal Models to Detect Antidepressants. In: Skolnick, P. (eds) Antidepressants. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-474-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-59259-474-0_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-048-9
Online ISBN: 978-1-59259-474-0
eBook Packages: Springer Book Archive